Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Varun Mehra

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|September 5, 2025
Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UKPaolo Antonio Muraro, Majid Kazmi, Eleonora De Matteis, et al.
The European Respiratory Journal|July 25, 2020
Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosisDarius Armstrong-James, Jonathan Youngs, Tihana Bicanic, et al.
Cancer Cell|October 31, 2021
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipientsPatrick Harrington, Katie J Doores, Chandan Saha, et al.
Leukemia|July 17, 2023
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)Simone Cesaro, Malgorzata Mikulska, Hans H Hirsch, et al.
Transplantation and Cellular Therapy|March 27, 2026
Transportability to the European population of Efficacy of Belumosudil as Compared with Physician's Choice of Best Available Therapy for The Treatment of Chronic Graft Versus Host DiseaseDaniel Wolff, Carlos Solano, David Michonneau, et al.
British Journal of Haematology|June 11, 2025
Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK: A 20-year retrospective analysis of activity and haematological outcomes from the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT)Majid Kazmi, Paolo A Muraro, Varun Mehra, et al.
Frontiers in Transplantation|July 12, 2024
Systematic screening and focused evaluation for veno-occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatmentDaniele Avenoso, Michelle Kenyon, Varun Mehra, et al.
Leukemia|April 29, 2022
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)Simone Cesaro, Per Ljungman, Malgorzata Mikulska, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2019
Epstein-Barr Virus and Monoclonal Gammopathy of Clinical Significance in Autologous Stem Cell Transplantation for Multiple SclerosisVarun Mehra, Elijah Rhone, Stefani Widya, et al.
Bone Marrow Transplantation|March 7, 2026
Chronic graft-versus-host disease: Current situation and unmet needs - A European position statementFlorent Malard, Zinaida Peric, Annalisa Ruggeri, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Journal of Neurology, Neurosurgery, and Psychiatry|September 5, 2025
Real-world effectiveness of autologous haematopoietic stem cell transplantation for multiple sclerosis in the UKPaolo Antonio Muraro, Majid Kazmi, Eleonora De Matteis, et al.
The European Respiratory Journal|July 25, 2020
Confronting and mitigating the risk of COVID-19 associated pulmonary aspergillosisDarius Armstrong-James, Jonathan Youngs, Tihana Bicanic, et al.
Cancer Cell|October 31, 2021
Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipientsPatrick Harrington, Katie J Doores, Chandan Saha, et al.
Leukemia|July 17, 2023
Update of recommendations for the management of COVID-19 in patients with haematological malignancies, haematopoietic cell transplantation and CAR T therapy, from the 2022 European Conference on Infections in Leukaemia (ECIL 9)Simone Cesaro, Malgorzata Mikulska, Hans H Hirsch, et al.
Transplantation and Cellular Therapy|March 27, 2026
Transportability to the European population of Efficacy of Belumosudil as Compared with Physician's Choice of Best Available Therapy for The Treatment of Chronic Graft Versus Host DiseaseDaniel Wolff, Carlos Solano, David Michonneau, et al.
British Journal of Haematology|June 11, 2025
Autologous haematopoietic stem cell transplantation for multiple sclerosis in the UK: A 20-year retrospective analysis of activity and haematological outcomes from the British Society of Blood and Marrow Transplantation and Cellular Therapy (BSBMTCT)Majid Kazmi, Paolo A Muraro, Varun Mehra, et al.
Frontiers in Transplantation|July 12, 2024
Systematic screening and focused evaluation for veno-occlusive disease/sinusoidal obstructive syndrome (VOD/SOS) following allogeneic stem cell transplant is associated with earlier diagnosis and prompt institution of defibrotide treatmentDaniele Avenoso, Michelle Kenyon, Varun Mehra, et al.
Leukemia|April 29, 2022
Recommendations for the management of COVID-19 in patients with haematological malignancies or haematopoietic cell transplantation, from the 2021 European Conference on Infections in Leukaemia (ECIL 9)Simone Cesaro, Per Ljungman, Malgorzata Mikulska, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 14, 2019
Epstein-Barr Virus and Monoclonal Gammopathy of Clinical Significance in Autologous Stem Cell Transplantation for Multiple SclerosisVarun Mehra, Elijah Rhone, Stefani Widya, et al.
Bone Marrow Transplantation|March 7, 2026
Chronic graft-versus-host disease: Current situation and unmet needs - A European position statementFlorent Malard, Zinaida Peric, Annalisa Ruggeri, et al.
Pageof 5